Comparative efficacy of glucagon-like peptide 1 (GLP-1) receptor agonists, pioglitazone and vitamin E for liver histology among patients with nonalcoholic fatty liver disease: systematic review and pilot network meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Comparative efficacy of glucagon-like peptide 1 (GLP-1) receptor agonists, pioglitazone and vitamin E for liver histology among patients with nonalcoholic fatty liver disease: systematic review and pilot network meta-analysis of randomized controlled trials

Published:2023-02-06 Issue:3 Volume:17 Page:273-282
ISSN:1747-4124
Container-title:Expert Review of Gastroenterology & Hepatology
language:en
Short-container-title:Expert Review of Gastroenterology & Hepatology

Author:

Gu Yunpeng¹,Sun Lei²,He Yining²,Yang Luping³,Deng Chaohua²,Zhou Run⁴,Kong Tingting⁴,Zhang Wei¹,Chen Yutong⁴,Li Jie⁵⁶,Shi Junping⁷

Affiliation:

1. School of Public Health, Hangzhou Normal University, Zhejiang, Hangzhou, China

2. Medical School, Hangzhou Normal University, Zhejiang, China

3. Medical School, Zhejiang Chinese Medicine University, Zhejiang, Hangzhou, China

4. School of Nursing, Hangzhou Normal University, Zhejiang, Hangzhou, China

5. Department of Infectious Diseases, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China

6. Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, Jiangsu, China

7. The Department of Hepatology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou, Zhejiang, China

Funder

Zhejiang Provincial Basic Public Welfare

Publisher

Informa UK Limited

Subject

Gastroenterology,Hepatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474124.2023.2172397

Reference39 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes